000 | 03380nam a22004695i 4500 | ||
---|---|---|---|
001 | vtls000562551 | ||
003 | RU-ToGU | ||
005 | 20210922091000.0 | ||
007 | cr nn 008mamaa | ||
008 | 170213s2015 ne | s |||| 0|eng d | ||
020 |
_a9789401794695 _9978-94-017-9469-5 |
||
024 | 7 |
_a10.1007/978-94-017-9469-5 _2doi |
|
035 | _ato000562551 | ||
040 |
_aSpringer _cSpringer _dRU-ToGU |
||
050 | 4 | _aRM1-950 | |
072 | 7 |
_aMMG _2bicssc |
|
072 | 7 |
_aMED071000 _2bisacsh |
|
082 | 0 | 4 |
_a615 _223 |
245 | 1 | 0 |
_aDan Shen (Salvia miltiorrhiza) in Medicine _helectronic resource _bVolume 1. Biology and Chemistry / _cedited by Xijun Yan. |
260 |
_aDordrecht : _bSpringer Netherlands : _bImprint: Springer, _c2015. |
||
300 |
_aXXX, 212 p. 94 illus., 2 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
505 | 0 | _aMateria Medica and Plant Resource -- Distribution and Habitat of Danshen -- Biological Characters of Danshen -- A Study on the Cultivation of Danshen -- Danshen’s in vitro Culture -- Genetics and Breeding of Danshen -- Water Soluble Components of Danshen -- Liposoluble chemical constituents in Danshen. | |
520 | _aThis book reviews research on Dan Shen, compiles data from clinical trials and biological experiments, and summarizes the latest research advances. It covers the medicinal herb, herbal pieces, and new proprietary drugs that contain it; it also covers simple and compound, traditional and contemporary formulas, and addresses a broad range of subjects, including: standardized cultivation; biodiversity; effective substances and their biological activities; quality control; and clinical trials. The book goes on to present the clinical trials on Dantonic, especially focusing on its therapeutic effects for coronary heart disease. It discusses compound prescriptions and compatibilities, from the herbal piece level to composition level, and describes approaches to research on modern Chinese medicine. Volume 1 describes the biology and chemistry of Dan Shen, while Volume 2 focuses on pharmacology and quality control. Volume 3 describes the clinical research on Dan Shen. Editor Xijun Yan is the President of Tianjin Tasly Group and a Member of the TCM Standardization Technical Committee. Gathering contributions from more than 100 authors working in the field of pharmaceutical and clinical research, the book presents and analyzes the available information from multiple aspects, reflects the current status of Dan Shen research, and offers an essential reference work for further research and development. | ||
650 | 0 |
_amedicine. _9566220 |
|
650 | 0 |
_apharmacology. _9460043 |
|
650 | 0 |
_aComplementary medicine. _9460881 |
|
650 | 0 |
_aCardiology. _9302215 |
|
650 | 1 | 4 |
_aBiomedicine. _9566246 |
650 | 2 | 4 |
_aPharmacology/Toxicology. _9302222 |
650 | 2 | 4 |
_aComplementary & Alternative Medicine. _9308005 |
650 | 2 | 4 |
_aCardiology. _9302215 |
700 | 1 |
_aYan, Xijun. _eeditor. _9471348 |
|
710 | 2 |
_aSpringerLink (Online service) _9143950 |
|
773 | 0 | _tSpringer eBooks | |
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-94-017-9469-5 |
912 | _aZDB-2-SBL | ||
999 | _c417714 |